Brief: Arovella Therapeutics Seeks Trading Halt
08/10/2023 23:21
Oct 9 (Reuters) - Arovella Therapeutics Ltd ALA.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PROPOSED
IN-LICENSE
AGREEMENT
Source text for Eikon: ID:nASX1zbfKT
Further company coverage: ALA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO